References
- Sharp H L, Bridges R A, Krivit W, Freier E M. Cirrhosis associated with alpha-1-AT deficiency—a previously unrecognized inherited disorder. J Lab Clin Med 1969; 73: 934–939
- Sveger T. Liver disease in alpha-1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976; 294: 1316–1321
- Larsson C. Natural history and life expectancy in severe alpha-1-antitrypsin deficiency, PiZ. Acta Med Scand 1978; 204: 345–351
- Hodges J R, Millward-Sadler G H, Barbatis C, Wright R. Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med 1981; 304: 557–560
- Leevy C M, Tygstrup N. Standardization of nomenclature, diganostic criteria and diagnostic methodology for diseases of the liver and biliary tract. S. Karger, Basel 1976
- Carlson J, Eriksson S. Chronic cryptogenic liver disease and malignant hepatoma in intermediate alpha-1-antitrypsin deficiency identified by a PiZ specific monoclonal antibody. Alpha-1-anti-trypsin and the liver. Clinical and biosynthetic studies. Thesis, University of Lund, MalmoSweden 1984
- Lieberman J. Heterozygous MZ alpha-1-antitrypsin deficiency in liver disease. N Engl J Med 1981; 305: 171
- Carlson J, Eriksson S, Hagerstrand I. Intra- and extra-cellular alpha-1-antitrypsin in liver disease with special reference to Pi phenotype. J Clin Pathol 1981; 34: 1020–1025
- Brand B, Bezahlev G H, Gould R. Cirrhosis and heterozygous FZ alpha-1-antitrypsin deficiency in an adult. Case report and review of the literature. Gastroenterology 1974; 66: 264–268
- Campar J L, Craig J R, Peters R L, Reynolds T B. Cirrhosis associated with partial deficiency of alpha-1-antitrypsin in an adult. Ann Intern Med 1973; 78: 233–238
- McGrath K M, Lilleyman J S, Triger D R, Underwood J CE. Liver disease complicating severe haemophilia in childhood. Arch Dis Child 1980; 55: 537–540
- Clarke M, Tanner M S. Alpha-1-antitrypsin deficiency and liver disease [Letter]. Br Med J 1981; 283: 1263
- Lieberman J, Silton R M, Agliozzo C M, McMahon J. Hepatocellular carcinoma and intermediate alpha-1-antitrypsin deficiency (MZ phenotype). Am J Clin Pathol 1975; 64: 304–310
- Rawlings W, Jr, Moss J, Cooper S, Hamilton S R. Hepatocellular carcinoma and partial deficiency of alpha-1-antitrypsin (MZ). Am J Intern Med 1974; 81: 771–773
- Eriksson S, Moestrup T, Hagerstrand I. Liver, lung and malignant disease in heterozygous (PiMZ) alpha-1-antitrypsin deficiency. Acta Med Scand 1975; 198: 243–247
- Blenkinsopp W K, Haffenden G P. Alpha-1-anti-trypsin bodies in the liver. J Clin Pathol 1977; 30: 132–137
- Fisher R L, Taylor L, Sherlock S. Alpha-1-anti-trypsin deficiency in liver disease: the extent of the problem. Gastroenterology 1976; 71: 646–651
- Kueppers F, Dickson E R, Summerskill W HJ. Alpha-1-antitrypsin phenotypes in chronic active liver disease and primary liver cirrhosis. Mayo Clinic Proc 1976; 51: 286–288
- Morin T, Martin J-P, Feldman G, Rueff B, Benhamou J P, Ropartz C. Heterozygous alpha-1-antitrypsin deficiency and cirrhosis in adults, a fortuitous association. Lancet 1975; 1: 250–251
- Theodoropulos G, Fertakis A, Archimantritis A, Kapordelis C, Angelopulos B. Alpha-1-antitrypsin phenotypes in cirrhosis and hepatoma. Hepatogastroenterology 1976; 23: 114–117
- Shepard H A, Selby W S, Chapman R WC, et al. Ulcerative colitis and persistent liver dysfunction. Q J Med 1983; 52: 503–513
- Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha-1-antitrypsin deficiency. N Engl J Med 1986; 314: 736–739